Belda-Antolí Mariola, Ros Bernal Francisco A, Vicente-Mampel Juan
School of Medicine and Health Science, Department of Physiotherapy, Catholic University of Valencia, 46002 Valencia, Spain.
Predepartamental Unit of Medicine, School of Health Sciences, Universitat Jaume I, 12006 Castellón de la Plana, Spain.
Mar Drugs. 2025 Jun 27;23(7):270. doi: 10.3390/md23070270.
Chronic pain affects approximately 20% of the global adult population, posing significant healthcare and economic challenges. Effective management requires addressing both biological and psychosocial factors, with emerging therapies such as antioxidants and marine algae offering promising new treatment avenues. Marine algae synthesize bioactive compounds, including polyphenols, carotenoids, and sulfated polysaccharides, which modulate oxidative stress, inflammation, and neuroimmune signaling pathways implicated in pain. Both preclinical and clinical studies support their potential application in treating inflammatory, neuropathic, muscular, and chronic pain conditions. Notable constituents include polyphenols, carotenoids (such as fucoxanthin), vitamins, minerals, and sulfated polysaccharides. These compounds modulate oxidative stress and inflammatory pathways, particularly by reducing reactive oxygen species (ROS) and downregulating cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Brown and red algae produce phlorotannins and fucoidans that alleviate pain and inflammation in preclinical models. Carotenoids like fucoxanthin demonstrate neuroprotective effects by influencing autophagy and inflammatory gene expression. Algal-derived vitamins (C and E) and minerals (magnesium, selenium, and zinc) contribute to immune regulation and pain modulation. Additionally, sulfated polysaccharides suppress microglial activation in the central nervous system (CNS). Marine algae represent a promising natural source of bioactive compounds with potential applications in pain management. Although current evidence, primarily derived from preclinical studies, indicates beneficial effects in various pain models, further research is necessary to confirm their efficacy, safety, and mechanisms in human populations. These findings advocate for the continued exploration of marine algae as complementary agents in future therapeutic strategies.
慢性疼痛影响着全球约20%的成年人口,带来了重大的医疗保健和经济挑战。有效的管理需要解决生物和心理社会因素,抗氧化剂和海藻等新兴疗法提供了有前景的新治疗途径。海藻合成生物活性化合物,包括多酚、类胡萝卜素和硫酸化多糖,这些化合物可调节与疼痛相关的氧化应激、炎症和神经免疫信号通路。临床前和临床研究均支持它们在治疗炎症性、神经性、肌肉性和慢性疼痛病症方面的潜在应用。值得注意的成分包括多酚、类胡萝卜素(如岩藻黄质)、维生素、矿物质和硫酸化多糖。这些化合物调节氧化应激和炎症途径,特别是通过减少活性氧(ROS)和下调细胞因子,如肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)。褐藻和红藻产生的间苯三酚和岩藻聚糖在临床前模型中可减轻疼痛和炎症。像岩藻黄质这样的类胡萝卜素通过影响自噬和炎症基因表达表现出神经保护作用。藻类衍生的维生素(C和E)和矿物质(镁、硒和锌)有助于免疫调节和疼痛调节。此外,硫酸化多糖可抑制中枢神经系统(CNS)中的小胶质细胞激活。海藻是一种有前景的生物活性化合物天然来源,在疼痛管理方面具有潜在应用。尽管目前的证据主要来自临床前研究,表明其在各种疼痛模型中具有有益作用,但仍需要进一步研究以确认它们在人群中的疗效、安全性和作用机制。这些发现主张在未来的治疗策略中继续探索海藻作为辅助药物。